Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Assets Average (2016 - 2025)

United Therapeutics (UTHR) has disclosed Assets Average for 16 consecutive years, with $7.6 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 5.14% to $7.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 billion through Dec 2025, up 5.14% year-over-year, with the annual reading at $7.6 billion for FY2025, 4.91% up from the prior year.
  • Assets Average hit $7.6 billion in Q4 2025 for United Therapeutics, roughly flat from $7.6 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $7.8 billion in Q2 2025 to a low of $4.6 billion in Q1 2021.
  • Historically, Assets Average has averaged $6.3 billion across 5 years, with a median of $6.6 billion in 2023.
  • Biggest five-year swings in Assets Average: grew 21.02% in 2023 and later rose 1.03% in 2024.
  • Year by year, Assets Average stood at $5.1 billion in 2021, then grew by 15.74% to $5.9 billion in 2022, then grew by 19.99% to $7.1 billion in 2023, then rose by 2.09% to $7.2 billion in 2024, then rose by 5.14% to $7.6 billion in 2025.
  • Business Quant data shows Assets Average for UTHR at $7.6 billion in Q4 2025, $7.6 billion in Q3 2025, and $7.8 billion in Q2 2025.